IR-Med Gestione

Gestione criteri di controllo 2/4

We currently do not have sufficient information about the CEO.

Informazioni chiave

Ran Ziskind

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	less than a year
Proprietà del CEO	n/a
Durata media del management	3.6yrs
Durata media del Consiglio di amministrazione	3.9yrs

Aggiornamenti recenti sulla gestione

Recent updates

AMMINISTRATORE DELEGATO

Ran Ziskind

less than a year

Mandato

Mr. Ran Ziskind is Chief Executive Officer of IR-Med Inc. from September 1, 2024. Mr. Ziskind is a highly experienced high-tech innovator and company leader with two decades of expertise in launching, deve...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Oded Bashan	Co-Founder & Chairman	11.2yrs	US$273.73k	12.16% $ 4.3m
Aharon Klein	Co-Founder	11.2yrs	US$101.07k	11.1% $ 3.9m
Aharon Binur	Chief Development Officer	3.6yrs	US$252.67k	0% $ 0
Ran Ziskind	Chief Executive Officer	less than a year	Nessun dato	Nessun dato
Yaniv Cohen	Co-Founder	1.8yrs	Nessun dato	11.1% $ 3.9m
Sharon Levkoviz	CFO, Treasurer & Secretary	3.9yrs	Nessun dato	0% $ 0
Avi Vachnis	Head of Software & AI	3.3yrs	Nessun dato	Nessun dato

3.6yrs

Durata media

60yo

Età media

Gestione esperta: IRME's management team is considered experienced (3.6 years average tenure).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Oded Bashan	Co-Founder & Chairman	11.2yrs	US$273.73k	12.16% $ 4.3m
Aharon Klein	Co-Founder	11.2yrs	US$101.07k	11.1% $ 3.9m
Yaniv Cohen	Co-Founder	3.9yrs	Nessun dato	11.1% $ 3.9m
Ohad Bashan	Director	3.9yrs	Nessun dato	0% $ 0
Richard Serbin	Member of Advisory Board	1.2yrs	Nessun dato	Nessun dato
Ron Mayron	Independent Director	3.9yrs	US$78.50k	0% $ 0
David Levy	Director of IR-Med Ltd	9.8yrs	Nessun dato	Nessun dato
Lynn Eschenbacher	Member of Advisory Board	no data	Nessun dato	Nessun dato
Avital Rosenberg	Independent Director	less than a year	Nessun dato	Nessun dato

3.9yrs

Durata media

62yo

Età media

Consiglio di amministrazione esperto: IRME's board of directors are considered experienced (3.9 years average tenure).

IR-Med Gestione

Gestione criteri di controllo 2/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

IR-Med Inc. Announces Chief Executive Officer Changes

IR-Med Inc. Appoints Avital Rosenberg as A Class I Director and Member of the Audit Committee

IR-Med Inc., Annual General Meeting, Nov 07, 2023

IR-MED Announces Executive Changes Effective as of October 15, 2023

IR-Med Inc. Appoints Richard Serbin, Esq. to Its Advisory Board

IR-Med Inc. Appoints Lynn Eschenbacher to its Advisory Board

Recent updates

IR-Med Inc. Announces Chief Executive Officer Changes

IR-Med Inc. Receives $500,000 Grant from the Israel Innovation Authority to Develop its Platform Technology for the Early Detection of Diabetic Foot Ulcers

IR-Med Inc. has filed an IPO in the amount of $8 million.

IR-Med Inc. Appoints Avital Rosenberg as A Class I Director and Member of the Audit Committee

IR-Med Inc.’s PressureSafe Reduced Pressure Injuries by 50% During a Usability Study with Clalit, Israel’s Hmo

IR-Med Inc.'S PressureSafe Receives FDA Listing for the Indication of Decision Support Device for Pressure Injuries

IR-MED to Report New Clinical Efficacy Data for Detection of Pressure Injuries with its AI- Based PressureSafe™ Device at NPIAP 2024 Annual Conference on February 16

IR-Med Inc., Annual General Meeting, Nov 07, 2023

IR-MED Announces Executive Changes Effective as of October 15, 2023

Ir-Med to Conduct Usability Study with Methodist Healthcare of San Antonio for Its Pressuresafe Device Which Is Slated for U.S. Launch in H1 2024

IR-Med Inc. Appoints Richard Serbin, Esq. to Its Advisory Board

Ir-Med Inc. Announces Interim Results from A Clinical Study of Pressuresafe

IR-Med Inc. Appoints Lynn Eschenbacher to its Advisory Board

IR-Med Inc., Annual General Meeting, Dec 12, 2022

IR-Med Announces Appointment of Moshe Gerber as Chief Executive Officer

International Display Advertising, Inc. (OTCPK:IDAD.D) completed the acquisition of IR Med, Ltd.

International Display Advertising, Inc. announced that it expects to receive $5 million in funding

AMMINISTRATORE DELEGATO

Mandato

Gruppo dirigente

Durata media

Età media

Membri del Consiglio di amministrazione

Durata media

Età media